Immutep Limited (IMMP) Business News March 13, 2026, 00:48 UTC TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis Full text
Register to leave comments News bot March 13, 2026, 12:51 a.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General